177Lu-NYM096
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 177Lu-NYM096, covering 2025-12-31 to 2025-12-31. Get the full timeline:
Most recent: Clinical Trial Update: 68Ga-NYM096/177Lu-NYM096 in Metastatic ccRCC [Phase 1]